Background Molecular diagnosis is crucial for biomarker-assisted glioma resection and
management. However, some limitations of current molecular diagnostic techniques prevent …

Diffuse gliomas are the most common primary brain malignancy in adults. Treatment is
usually multimodal, with surgery followed by radiotherapy and chemotherapy. There has …

Background Glioblastoma is the most common primary brain malignancy, yet treatment
options are limited, and prognosis remains guarded. Individualized tumor genetic …

Background Accurate characterization of glioma is crucial for clinical decision making. A
delineation of the tumor is also desirable in the initial decision stages but is time-consuming …

Simple Summary Gliomas comprise 80% of all malignant brain tumors. We aimed to develop
a deep learning-based framework for the automatic segmentation and characterization of …

Background IDH mutation and 1p/19q codeletion status are important prognostic markers for
glioma that are currently determined using invasive procedures. Our goal was to develop …

Molecular genetics is highly related with prognosis of high-grade glioma. Accordingly, the
latest WHO guideline recommends that molecular subgroups of the genes, including IDH …

OBJECTIVE The aim of this study was to build a convolutional neural network (CNN)–based
prediction model of glioblastoma (GBM) molecular subtype diagnosis and prognosis with …

Purpose Surgery is the predominant treatment modality of human glioma but suffers difficulty
on clearly identifying tumor boundaries in clinic. Conventional practice involves …

BACKGROUND: With the advent of the molecular era, the diagnosis and treatment systems
of glioma have also changed. A single histological type cannot be used for prognosis grade …